565 related articles for article (PubMed ID: 36869790)
21. Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.
Garay-Sevilla ME; Gomez-Ojeda A; González I; Luévano-Contreras C; Rojas A
Mol Cell Biochem; 2021 Mar; 476(3):1555-1573. PubMed ID: 33398664
[TBL] [Abstract][Full Text] [Related]
22. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
23. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
24. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
Teissier T; Boulanger É
Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
[TBL] [Abstract][Full Text] [Related]
25. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
26. Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic Implications.
Schröter D; Höhn A
Curr Pharm Des; 2018; 24(44):5245-5251. PubMed ID: 30706806
[TBL] [Abstract][Full Text] [Related]
27. Activation of the receptor for advanced glycation end products and consequences on health.
Wautier MP; Guillausseau PJ; Wautier JL
Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
[TBL] [Abstract][Full Text] [Related]
28. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
29. Age-Influenced Receptors of Advanced Glycation End Product Overexpression Associated With Osteogenic Differentiation Impairment in Patients With Type 2 Diabetes.
Phimphilai M; Pothacharoen P; Kongtawelert P
Front Endocrinol (Lausanne); 2021; 12():726182. PubMed ID: 34512554
[TBL] [Abstract][Full Text] [Related]
30. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
[TBL] [Abstract][Full Text] [Related]
31. Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
Dozio E; Vianello E; Bandera F; Longhi E; Brizzola S; Nebuloni M; Corsi Romanelli MM
Mediators Inflamm; 2019; 2019():2712376. PubMed ID: 30944546
[TBL] [Abstract][Full Text] [Related]
32. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
[TBL] [Abstract][Full Text] [Related]
33. RAGE Signaling in Melanoma Tumors.
Olaoba OT; Kadasah S; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110
[TBL] [Abstract][Full Text] [Related]
34. The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes.
Snelson M; Lucut E; Coughlan MT
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163688
[TBL] [Abstract][Full Text] [Related]
35. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
[TBL] [Abstract][Full Text] [Related]
36. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection.
Vella V; Malaguarnera R; Nicolosi ML; Morrione A; Belfiore A
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118522. PubMed ID: 31394114
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.
Ishibashi Y; Matsui T; Maeda S; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2013 Aug; 12():125. PubMed ID: 23984879
[TBL] [Abstract][Full Text] [Related]
38. RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer.
Muoio MG; Pellegrino M; Rapicavoli V; Talia M; Scavo G; Sergi V; Vella V; Pettinato S; Galasso MG; Lappano R; Scordamaglia D; Cirillo F; Pulvirenti A; Rigiracciolo DC; Maggiolini M; Belfiore A; De Francesco EM
Breast Cancer Res; 2023 Jul; 25(1):84. PubMed ID: 37461077
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma.
Nguyen DV; Linderholm A; Haczku A; Kenyon N
Pharmacol Ther; 2017 Dec; 180():139-143. PubMed ID: 28648831
[TBL] [Abstract][Full Text] [Related]
40. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development.
Du C; Whiddett RO; Buckle I; Chen C; Forbes JM; Fotheringham AK
Cells; 2022 Nov; 11(21):. PubMed ID: 36359899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
